Literature DB >> 28515149

Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation.

Katherine Tech1,2, Andrey P Tikunov1, Hamza Farooq3,4, A Sorana Morrissy3,4, Jessica Meidinger2, Taylor Fish2, Sarah C Green1, Hedi Liu2, Yisu Li5, Andrew J Mungall5, Richard A Moore5, Yussanne Ma5, Steven J M Jones5, Marco A Marra5, Matthew G Vander Heiden6,7, Michael D Taylor3,4,8,9, Jeffrey M Macdonald1, Timothy R Gershon10,11,12.   

Abstract

Aerobic glycolysis supports proliferation through unresolved mechanisms. We have previously shown that aerobic glycolysis is required for the regulated proliferation of cerebellar granule neuron progenitors (CGNP) and for the growth of CGNP-derived medulloblastoma. Blocking the initiation of glycolysis via deletion of hexokinase-2 (Hk2) disrupts CGNP proliferation and restricts medulloblastoma growth. Here, we assessed whether disrupting pyruvate kinase-M (Pkm), an enzyme that acts in the terminal steps of glycolysis, would alter CGNP metabolism, proliferation, and tumorigenesis. We observed a dichotomous pattern of PKM expression, in which postmitotic neurons throughout the brain expressed the constitutively active PKM1 isoform, while neural progenitors and medulloblastomas exclusively expressed the less active PKM2. Isoform-specific Pkm2 deletion in CGNPs blocked all Pkm expression. Pkm2-deleted CGNPs showed reduced lactate production and increased SHH-driven proliferation. 13C-flux analysis showed that Pkm2 deletion reduced the flow of glucose carbons into lactate and glutamate without markedly increasing glucose-to-ribose flux. Pkm2 deletion accelerated tumor formation in medulloblastoma-prone ND2:SmoA1 mice, indicating the disrupting PKM releases CGNPs from a tumor-suppressive effect. These findings show that distal and proximal disruptions of glycolysis have opposite effects on proliferation, and that efforts to block the oncogenic effect of aerobic glycolysis must target reactions upstream of PKM. Cancer Res; 77(12); 3217-30. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28515149      PMCID: PMC5497486          DOI: 10.1158/0008-5472.CAN-16-3304

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Genes involved in cerebellar cell specification and differentiation.

Authors:  M E Hatten; J Alder; K Zimmerman; N Heintz
Journal:  Curr Opin Neurobiol       Date:  1997-02       Impact factor: 6.627

3.  Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Authors:  Matthew G Vander Heiden; Jason W Locasale; Kenneth D Swanson; Hadar Sharfi; Greg J Heffron; Daniel Amador-Noguez; Heather R Christofk; Gerhard Wagner; Joshua D Rabinowitz; John M Asara; Lewis C Cantley
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

4.  Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferation.

Authors:  Bentley Varghese; Gayathri Swaminathan; Alexander Plotnikov; Christos Tzimas; Ning Yang; Hallgeir Rui; Serge Y Fuchs
Journal:  Mol Endocrinol       Date:  2010-10-20

Review 5.  Medulloblastoma: developmental mechanisms out of control.

Authors:  Silvia Marino
Journal:  Trends Mol Med       Date:  2005-01       Impact factor: 11.951

6.  Metabolomic investigations of American oysters using H-NMR spectroscopy.

Authors:  Andrey P Tikunov; Christopher B Johnson; Haakil Lee; Michael K Stoskopf; Jeffrey M Macdonald
Journal:  Mar Drugs       Date:  2010-10-08       Impact factor: 5.118

Review 7.  Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.

Authors:  E Eigenbrodt; M Reinacher; U Scheefers-Borchel; H Scheefers; R Friis
Journal:  Crit Rev Oncog       Date:  1992

8.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

9.  Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.

Authors:  I Garcia; A J Crowther; V Gama; C R Miller; C Ryan Miller; M Deshmukh; T R Gershon
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

10.  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.

Authors:  Dimitrios Anastasiou; Yimin Yu; William J Israelsen; Jian-Kang Jiang; Matthew B Boxer; Bum Soo Hong; Wolfram Tempel; Svetoslav Dimov; Min Shen; Abhishek Jha; Hua Yang; Katherine R Mattaini; Christian M Metallo; Brian P Fiske; Kevin D Courtney; Scott Malstrom; Tahsin M Khan; Charles Kung; Amanda P Skoumbourdis; Henrike Veith; Noel Southall; Martin J Walsh; Kyle R Brimacombe; William Leister; Sophia Y Lunt; Zachary R Johnson; Katharine E Yen; Kaiko Kunii; Shawn M Davidson; Heather R Christofk; Christopher P Austin; James Inglese; Marian H Harris; John M Asara; Gregory Stephanopoulos; Francesco G Salituro; Shengfang Jin; Lenny Dang; Douglas S Auld; Hee-Won Park; Lewis C Cantley; Craig J Thomas; Matthew G Vander Heiden
Journal:  Nat Chem Biol       Date:  2012-10       Impact factor: 15.040

View more
  21 in total

Review 1.  Pyruvate kinase M2: A simple molecule with complex functions.

Authors:  Mohammed Alquraishi; Dexter L Puckett; Dina S Alani; Amal S Humidat; Victoria D Frankel; Dallas R Donohoe; Jay Whelan; Ahmed Bettaieb
Journal:  Free Radic Biol Med       Date:  2019-08-08       Impact factor: 7.376

2.  Cancer-associated mutations in human pyruvate kinase M2 impair enzyme activity.

Authors:  Vivian M Liu; Andrea J Howell; Aaron M Hosios; Zhaoqi Li; William J Israelsen; Matthew G Vander Heiden
Journal:  FEBS Lett       Date:  2019-11-16       Impact factor: 4.124

3.  A Survey of the Metabolic Landscape of the Developing Cerebellum at Single-Cell Resolution.

Authors:  James R Krycer; Sam P Nayler
Journal:  Cerebellum       Date:  2022-06-29       Impact factor: 3.648

4.  Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma.

Authors:  Daniel R Schmidt; Julia E Heyman; James P O'Brien; Amy C Liu; Shawn M Davidson; William J Israelsen; Talya L Dayton; Raghav Sehgal; Roderick T Bronson; Elizaveta Freinkman; Howard H Mak; Giuseppe Nicolò Fanelli; Scott Malstrom; Gary Bellinger; Arkaitz Carracedo; Pier Paolo Pandolfi; Kevin D Courtney; Abhishek Jha; Ronald A DePinho; James W Horner; Craig J Thomas; Lewis C Cantley; Massimo Loda; Matthew G Vander Heiden
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

5.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.

Authors:  Kirsten L Bryant; Clint A Stalnecker; Daniel Zeitouni; Jennifer E Klomp; Sen Peng; Andrey P Tikunov; Venugopal Gunda; Mariaelena Pierobon; Andrew M Waters; Samuel D George; Garima Tomar; Björn Papke; G Aaron Hobbs; Liang Yan; Tikvah K Hayes; J Nathaniel Diehl; Gennifer D Goode; Nina V Chaika; Yingxue Wang; Guo-Fang Zhang; Agnieszka K Witkiewicz; Erik S Knudsen; Emanuel F Petricoin; Pankaj K Singh; Jeffrey M Macdonald; Nhan L Tran; Costas A Lyssiotis; Haoqiang Ying; Alec C Kimmelman; Adrienne D Cox; Channing J Der
Journal:  Nat Med       Date:  2019-03-04       Impact factor: 53.440

6.  Pyruvate Kinase M2 Supports Muscle Progenitor Cell Proliferation but Is Dispensable for Skeletal Muscle Regeneration after Injury.

Authors:  Jamie E Blum; Brandon J Gheller; Abby Benvie; Martha S Field; Elena Panizza; Nathaniel M Vacanti; Daniel Berry; Anna Thalacker-Mercer
Journal:  J Nutr       Date:  2021-11-02       Impact factor: 4.687

7.  MYC Drives Group 3 Medulloblastoma through Transformation of Sox2+ Astrocyte Progenitor Cells.

Authors:  Ran Tao; Najiba Murad; Zhenhua Xu; Peng Zhang; Konstantin Okonechnikov; Marcel Kool; Samuel Rivero-Hinojosa; Christopher Lazarski; Pan Zheng; Yang Liu; Charles G Eberhart; Brian R Rood; Roger Packer; Yanxin Pei
Journal:  Cancer Res       Date:  2019-03-12       Impact factor: 13.312

8.  Isoform-specific deletion of PKM2 constrains tumor initiation in a mouse model of soft tissue sarcoma.

Authors:  Talya L Dayton; Vasilena Gocheva; Kathryn M Miller; Arjun Bhutkar; Caroline A Lewis; Roderick T Bronson; Matthew G Vander Heiden; Tyler Jacks
Journal:  Cancer Metab       Date:  2018-05-31

9.  High-resolution transcriptional landscape of xeno-free human induced pluripotent stem cell-derived cerebellar organoids.

Authors:  Samuel Nayler; Devika Agarwal; Fabiola Curion; Rory Bowden; Esther B E Becker
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

10.  PKM2 is not required for colon cancer initiated by APC loss.

Authors:  Allison N Lau; William J Israelsen; Jatin Roper; Mark J Sinnamon; Larissa Georgeon; Talya L Dayton; Alissandra L Hillis; Omer H Yilmaz; Dolores Di Vizio; Kenneth E Hung; Matthew G Vander Heiden
Journal:  Cancer Metab       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.